Efficacy of metformin combined with vitamin D in the treatment of polycystic ovarian syndrome: A meta-analysis

Li Xiang, Min Liao, Yuyin Su

Abstract

Polycystic ovary syndrome (PCOS), as an endocrine and metabolic disorder, affects approximately 6% -20% of women of childbearing age. This study aims to assess the therapeutic effects of Metformin combined with vitamin D in PCOS patients. Eight databases were searched to obtain randomized controlled trials, both domestically and internationally, on the effects of Metformin combined with vitamin D in patients with PCOS. Data analysis was performed using RevMan 5.3 software. Nine studies were ultimately included in this meta-analysis. Six studies reported the homeostatic model assessment for insulin resistance of the test group and the control group, which was significantly lower (SMD: -0.23; 95% Cl: -0.42,-0.04; P<0.05) than the control group, body mass index (BMI) (SMD: -1.86; 95% Cl: -2.77,-0.96; P<0.01), Serum 25 (OH) D (SMD: 14.28; 95% Cl: 12.26,16.29; P<0.01), testosterone (SMD: -0.11; 95% Cl: -0.15,-0.07; P<0.01) and regulated menstrual cycles (OR: 1.27; 95% Cl: 0.99,1.63; P=0.063). Our meta-analysis of nine trials demonstrates significant reductions in insulin resistance, BMI, and testosterone levels, along with increased serum vitamin D levels and improved menstrual cycle regulation after Metformin and vitamin D treatment. These findings suggest the potential of this combined therapy in managing the multifaceted aspects of PCOS. (Afr J Reprod Health 2024; 28 [2]: 43-54).

Full Text:

PDF

References

Chen W and Pang Y. Metabolic Syndrome and PCOS:

Pathogenesis and the Role of Metabolites.

Metabolites. 2021;11(12).

Escobar-Morreale HF. Polycystic ovary syndrome:

definition, aetiology, diagnosis and treatment. Nat

Rev Endocrinol. 2018;14(5):270-284.

Powers SE, Uliassi NW, Sullivan SD, Tuchman LK, Mehra

R, Gomez-Lobo V. Trends in standard workup

performed by pediatric subspecialists for the

diagnosis of adolescent polycystic ovary syndrome.

J Pediatr Adolesc Gynecol. 2015;28(1):43-46.

Sprung VS, Atkinson G, Cuthbertson DJ, Pugh CJ, Aziz N,

Green DJ, Cable NT and Jones H. Endothelial

function measured using flow-mediated dilation in

polycystic ovary syndrome: a meta-analysis of the

observational studies. Clin Endocrinol (Oxf).

;78(3):438-446.

Barber TM, McCarthy MI, Wass JA and Franks S. Obesity

and polycystic ovary syndrome. Clin Endocrinol

(Oxf). 2006;65(2):137-145.

Lim SS, Davies MJ, Norman RJ and Moran LJ. Overweight,

obesity and central obesity in women with polycystic

ovary syndrome: a systematic review and metaanalysis. Hum Reprod Update. 2012;18(6):618-637.

Apridonidze T, Essah PA, Iuorno MJ and Nestler JE.

Prevalence and characteristics of the metabolic

syndrome in women with polycystic ovary

syndrome. J Clin Endocrinol Metab.

;90(4):1929-1935.

Barber TM, Franks S. Obesity and polycystic ovary

syndrome. Clin Endocrinol (Oxf). 2021;95(4):531-

Abu Hashim H, Foda O and El Rakhawy M. Unilateral or

bilateral laparoscopic ovarian drilling in polycystic

ovary syndrome: a meta-analysis of randomized

trials. Arch Gynecol Obstet. 2018;297(4):859-870.

Song SY, Yang JB, Song MS, Oh HY, Lee GW, Lee M, Ko

YB, Lee KH, Chang HK, Kwak SM and Yoo HJ.

Effect of pretreatment with combined oral

contraceptives on outcomes of assisted reproductive

technology for women with polycystic ovary

syndrome: a meta-analysis. Arch Gynecol Obstet.

Sep;300(3):737-750.

Abdolahian S, Tehrani FR, Amiri M, Ghodsi D, Yarandi

RB, Jafari M, Majd HA, Nahidi F. Effect of lifestyle

modifications on anthropometric, clinical and

biochemical parameters in adolescent girls with

polycystic ovary syndrome: a systematic review and

meta-analysis. BMC Endocr Disord. 2020 May

;20(1):71..

Morgante G, Massaro MG, Di Sabatino A, Cappelli V and

De Leo V. Therapeutic approach for metabolic

disorders and infertility in women with PCOS.

Gynecol Endocrinol. 2018;34(1):4-9.

Misso ML and Teede HJ. Metformin in women with PCOS,

cons. Endocrine. 2015;48(2):428-433.

Sanchez-Rangel E and Inzucchi SE. Metformin: clinical

use in type 2 diabetes. Diabetologia.

;60(9):1586-1593.

Zhou J, Massey S, Story D and Li L. Metformin: An Old

Drug with New Applications. Int J Mol Sci.

;19(10).

Zhao H, Xing C, Zhang J and He B. Comparative efficacy

of oral insulin sensitizers metformin,

thiazolidinediones, inositol, and berberine in

improving endocrine and metabolic profiles in

women with PCOS: a network meta-analysis. Reprod

Health. 2021;18(1):171.

Shao R, Li X, Feng Y, Lin JF and Billig H. Direct effects

of metformin in the endometrium: a hypothetical

mechanism for the treatment of women with PCOS

and endometrial carcinoma. J Exp Clin Cancer Res.

;33(1):41.

Irani M and Merhi Z. Role of vitamin D in ovarian

physiology and its implication in reproduction: a

systematic review. Fertil Steril. 2014;102(2):460-

e463.

Aleyasin A, Hosseini MA, Mahdavi A, Safdarian L, Fallahi

P, Mohajeri MR, Abbasi M, Esfahani F. Predictive

value of the level of vitamin D in follicular fluid on

the outcome of assisted reproductive technology. Eur

J Obstet Gynecol Reprod Biol. 2011

Nov;159(1):132-7.

Kadoura S, Alhalabi M and Nattouf AH. Effect of Calcium

and Vitamin D Supplements as an Adjuvant Therapy

to Metformin on Menstrual Cycle Abnormalities,

Hormonal Profile, and IGF-1 System in Polycystic

Ovary Syndrome Patients: A Randomized, PlaceboControlled Clinical Trial. Adv Pharmacol Sci.

;2019:9680390.

Jia XZ, Wang YM, Zhang N, Guo LN, Zhen XL, Li H and

Wei L. Effect of vitamin D on clinical and

biochemical parameters in polycystic ovary

syndrome women: A meta-analysis. J Obstet

Gynaecol Res. 2015 Nov;41(11):1791-802.

Garg G, Kachhawa G, Ramot R, Khadgawat R, Tandon N,

Sreenivas V, Kriplani A and Gupta N. Effect of

vitamin D supplementation on insulin kinetics and

cardiovascular risk factors in polycystic ovarian

syndrome: a pilot study. Endocr Connect. 2015

Jun;4(2):108-16.

Tehrani HG, Mostajeran F and Shahsavari S. The effect of

calcium and vitamin D supplementation on

menstrual cycle, body mass index and

hyperandrogenism state of women with poly cystic

ovarian syndrome. J Res Med Sci. 2014;19(9):875-

Firouzabadi R, Aflatoonian A, Modarresi S, Sekhavat L and

MohammadTaheri S. Therapeutic effects of calcium

& vitamin D supplementation in women with PCOS.

Complement Ther Clin Pract. 2012;18(2):85-88.

Sun J. The application effect of vitamin D combined with

metformin hydrochloride tablets in correcting insulin

resistance in patients with polycystic ovary

syndrome. Contemporary Medicine. 2022; 28: 144-

Zheng YH. Study on the efficacy of vitamin D3 combined

with metformin in the treatment of polycystic ovary

syndrome and the mechanism of action of vitamin

D3. China Maternal and Child Health. 2019; 34:

-5495.

Zhang S. The effect of metformin combined with vitamin

D on insulin resistance and uterine spiral artery

hemodynamic indicators in patients with PCOS.

Huaxia Medical Journal. 2021; 34: 112-116.

Zhou Q and An J. The effect of combined use of metformin

and vitamin D on metabolism in patients with

polycystic ovary syndrome. Chinese Journal of

Hemorheology. 2018; 28: 309-311.

Aleyasin A, Hosseini MA, Mahdavi A, Safdarian L, Fallahi

P, Mohajeri MR, Abbasi M and Esfahani F.

Predictive value of the level of vitamin D in follicular

fluid on the outcome of assisted reproductive

technology. Eur J Obstet Gynecol Reprod Biol. 2011

Nov;159(1):132-7.

Jia XZ, Wang YM, Zhang N, Guo LN, Zhen XL, Li H and

Wei L. Effect of vitamin D on clinical and

biochemical parameters in polycystic ovary

syndrome women: A meta-analysis. J Obstet

Gynaecol Res. 2015 Nov;41(11):1791-802.

Heidari B, Lerman A, Lalia AZ, Lerman LO and Chang

AY. Effect of Metformin on Microvascular

Endothelial Function in Polycystic Ovary Syndrome.

Mayo Clin Proc. 2019;94(12):2455-2466.

Guan Y, Wang D, Bu H, Zhao T and Wang H. The Effect

of Metformin on Polycystic Ovary Syndrome in

Overweight Women: A Systematic Review and

Meta-Analysis of Randomized Controlled Trials. Int

J Endocrinol. 2020;2020:5150684.

Thomson RL, Spedding S and Buckley JD. Vitamin D in

the aetiology and management of polycystic ovary

syndrome. Clin Endocrinol (Oxf). 2012;77(3):343-

Ozkan S, Jindal S, Greenseid K, Shu J, Zeitlian G, Hickmon

C and Pal L. Replete vitamin D stores predict

reproductive success following in vitro fertilization.

Fertil Steril. 2010 Sep;94(4):1314-1319. doi:

1016/j.fertnstert.2009.05.019. Epub 2009 Jul 8.

Bonakdaran S, Mazloom Khorasani Z, Davachi B and

Mazloom Khorasani J. The effects of calcitriol on

improvement of insulin resistance, ovulation and

comparison with metformin therapy in PCOS

patients: a randomized placebo- controlled clinical

trial. Iran J Reprod Med. 2012;10(5):465-472.

Refbacks

  • There are currently no refbacks.